Dimethylglyoxal plasma concentrations were also increased in leptin receptor-deficient db/db mice, an established type-2 diabetes mouse model, comparable to 3-deoxyglucosone and methylglyoxal (Fig. 1g and Supplementary Fig. 1e, f)25. This evidence concerns the gene LEPR and type 2 diabetes mellitus.